Pifithrin-α hydrobromide NEW
| Price | $33 | $52 | $81 |
| Package | 2mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-04 |
Product Details
| Product Name: Pifithrin-α hydrobromide | CAS No.: 63208-82-2 |
| Purity: 98.54% | Supply Ability: 10g |
| Release date: 2024/11/04 |
Product Introduction
Bioactivity
| 名稱 | Pifithrin-α hydrobromide |
| 描述 | Pifithrin-α hydrobromide (Pifithrin-α hydrobromide) is a p53 inhibitor, inhibiting p53-dependent transactivation of p53-responsive genes. |
| 細胞實驗 | At the end of cell treatments, the number of attached cells is estimated by staining with 0.25% crystal violet in 50% methanol, followed by elution of the dye with 1% SDS. Optical density (530 nm) reflecting the number of stained cells is determined with a Bio-Tek EL311 microplate reader. Cell viability in suspension of short term culture of primary thymocytes is determined by their staining with 0.1% of methyl blue and microscopic counting of blue (dead) cells.(Only for Reference) |
| 激酶實驗 | The ligand binding competition assays are performed. Cytosolic cell extracts from Hepa-1 cells are generated by the resuspension of the cell pellets in HEDG buffer [25 mM Hepes, 1 mM EDTA, 1 mM dithiothreitol, and 10% (v/v) glycerol, pH 7.5] containing 0.4 mM leupeptin, 4 mg/mL aprotinin, and 0.3 mM phenylmethylsulfonyl fluoride, homogenization, and centrifugation at 100,000 g for 45 min. Aliquots of the supernatant (120 μg) are incubated at room temperature for 2 h with the indicated concentrations of Pifithrin-α in the presence of 3 nM [3H]TCDD in HEDG buffer. After incubation on ice with hydroxyapatite for 30 min, HEDG buffer with 0.5% Tween 80 is added. The samples are centrifuged, washed twice, resuspended in 0.2 mL of scintillation fluid, and subjected to scintillation counting. Nonspecific binding is determined using a 150-fold molar excess of TCDF and subtracted from the total binding to obtain the specific binding. The specific binding is reported relative to [3H]TCDD alone[2]. |
| 體外活性 | At a concentration of 10 μM, Pifithrin-α inhibits apoptosis in C8 cells induced by Dox, Etoposide, Taxol, and Cytosine arabinoside. It also reduces activation of the heat shock transcription factor and enhances cell sensitivity to heat, lowers glucocorticoid receptor activation in HeLa cells, and protects murine thymocytes from apoptosis induced by Dexamethasone. Concentrations between 100–200 nM of Pifithrin-α completely block the increase in p53 DNA binding levels and the p53-responsive gene Bax in hippocampal cells induced by Camptothecin, while 200 nM safeguards cultured hippocampal neurons from death caused by DNA damage agents. Furthermore, 200 μM Pifithrin-α stabilizes mitochondrial function, inhibits caspase activation, and shields hippocampal neurons from death induced by glutamate and β-amyloid peptide. Pifithrin-α prevents the p53-dependent growth inhibition in human diploid fibroblasts following DNA damage, though it does not affect fibroblasts lacking p53. It can regulate the nuclear import and export of p53, or both, and decrease nuclear p53 stability. Pifithrin-α inhibits signals from heat shock and glucocorticoid receptors without affecting NF-κB signaling. |
| 體內(nèi)活性 | Intraperitoneal injection of 3.6 μg/kg Pifithrin-α in mice significantly inhibited Dex-induced thymic atrophy. Compared to the control group, Pifithrin-α (2 mg/kg) notably decreased the extent of motor dysfunction in rats with transient cerebral artery occlusion. Administration of Pifithrin-α (2 mg/kg i.p.) 30 minutes before treatment of cerebral artery occlusion in mice reduced ischemic brain damage and shielded hippocampal neurons from excitotoxicity damage. In C57BL and Balb/c mice, intraperitoneal injection of 2.2 mg/kg Pifithrin-α completely protected the mice against the lethal effects of 60% mortality gamma-ray irradiation. Pifithrin-α was observed to substantially lower cellular apoptosis in rats, evidenced by Tunel and caspase 3 staining. When administered within one hour after a stroke, animals treated with Pifithrin-α exhibited fewer motor dysfunctions and smaller infarcts. After 7 days of treatment with Pifithrin-α, rats showed significantly reduced scores of motor dysfunction compared to the placebo control group. |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | DMSO : 36.7 mg/mL (100 mM) |
| 關鍵字 | inhibit | Pifithrin-a (PFTa) HBr | Ferroptosis | Pifithrin α hydrobromide | Inhibitor | Aryl Hydrocarbon Receptor | MDM-2/p53 | Pifithrin-alpha | PFTa Hydrobromide | Pifithrin-alpha Hydrobromide | Pifithrin-a | AhR | Pifithrin | PFTalpha Hydrobromide | Pifithrin Hydrobromide | PFTalpha | Pifithrin-a Hydrobromide | Pifithrin-alpha (PFTalpha) HBr | Pifithrinα hydrobromide | PFTα Hydrobromide | Pifithrin-α Hydrobromide | PFTa |
| 相關產(chǎn)品 | TBHQ | Acetylcysteine | Rotenone | α-Vitamin E | Sorafenib | Curcumin | Artemisinin | Benzyl butyl phthalate | L-Cystine | L-Glutamic acid monosodium salt | Coenzyme Q10 | Indole-3-carbinol |
| 相關庫 | 抗肺癌化合物庫 | 抗結直腸癌化合物庫 | 糖代謝化合物庫 | 經(jīng)典已知活性庫 | 泛素化化合物庫 | 抗癌細胞代謝庫 | 抑制劑庫 | 抗衰老化合物庫 | 已知活性化合物庫 | 活性脂質化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $34.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-01 | |
| $10.00/25kg |
VIP2Y
|
Enki Biopharmaceuticals (Shanghai) Limited
|
2023-11-01 | |
| $0.00/25KG |
VIP4Y
|
Sinoway Industrial co., ltd.
|
2021-07-12 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY